1
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
1,105,210
$207.0m10.10%
10.10%
Reduced Shares held: Q3 2025 1.3m, Q4 2025 1.3m, Q1 2026 1.2m, Q2 2026 1.1m
-104.3k
-104,255
-8.6%
2
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
2,179,069
$123.8m6.04%
6.04%
Added Shares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 1.5m, Q2 2026 2.2m
+701.1k
+701,115
47.4%
3
ELI LILLY & CO
COM
LLY
LLY
98,700
$118.4m5.78%
5.78%
Unchanged Shares held: Q3 2025 105.4k, Q4 2025 105.4k, Q1 2026 98.7k, Q2 2026 98.7k
4
MADRIGAL PHARMACEUTICALS INC
COM
MDGL
MDGL
174,999
$94.0m4.59%
4.59%
Added Shares held: Q3 2025 137.7k, Q4 2025 139.6k, Q1 2026 171.0k, Q2 2026 175.0k
+4.0k
+4,000
2.3%
5
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
798,145
$93.4m4.56%
4.56%
Reduced Shares held: Q3 2025 761.1k, Q4 2025 762.3k, Q1 2026 811.3k, Q2 2026 798.1k
-13.1k
-13,149
-1.6%
6
RHYTHM PHARMACEUTICALS INC
COM
RYTM
RYTM
692,598
$76.9m3.75%
3.75%
Added Shares held: Q3 2025 717.1k, Q4 2025 695.0k, Q1 2026 689.7k, Q2 2026 692.6k
+2.9k
+2,850
0.4%
7
KYMERA THERAPEUTICS INC
COM
KYMR
KYMR
453,156
$52.0m2.54%
2.54%
Reduced Shares held: Q3 2025 450.4k, Q4 2025 496.9k, Q1 2026 496.9k, Q2 2026 453.2k
-43.7k
-43,715
-8.8%
8
ARGENX SE
SPONSORED ADR
ARGX
ARGX
52,750
$48.9m2.39%
2.39%
Reduced Shares held: Q3 2025 142.8k, Q4 2025 103.2k, Q1 2026 98.5k, Q2 2026 52.8k
-45.8k
-45,750
-46.5%
9
ASCENDIS PHARMA A/S
ORD SHS
ASND
ASND
168,750
$45.0m2.20%
2.20%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 168.8k
10
XENON PHARMACEUTICALS INC
COM
XENE
XENE
683,907
$41.3m2.01%
2.01%
Reduced Shares held: Q3 2025 851.7k, Q4 2025 787.8k, Q1 2026 763.0k, Q2 2026 683.9k
-79.1k
-79,113
-10.4%
11
SCHOLAR ROCK HLDG CORP
COM
SRRK
SRRK
715,452
$39.3m1.92%
1.92%
Reduced Shares held: Q3 2025 794.1k, Q4 2025 733.5k, Q1 2026 739.8k, Q2 2026 715.5k
-24.4k
-24,364
-3.3%
12
INSMED INC
COM PAR $.01
INSM
INSM
362,150
$38.6m1.88%
1.88%
Added Shares held: Q3 2025 385.0k, Q4 2025 319.2k, Q1 2026 314.3k, Q2 2026 362.1k
+47.9k
+47,850
15.2%
13
PENUMBRA INC
COM
PEN
PEN
115,750
$36.5m1.78%
1.78%
Reduced Shares held: Q3 2025 120.5k, Q4 2025 120.5k, Q1 2026 120.5k, Q2 2026 115.8k
-4.8k
-4,750
-3.9%
14
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
640,317
$34.4m1.68%
1.68%
Added Shares held: Q3 2025 951.2k, Q4 2025 748.2k, Q1 2026 640.2k, Q2 2026 640.3k
+100
+100
0.0%
15
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
967,855
$32.3m1.58%
1.58%
Reduced Shares held: Q3 2025 1.2m, Q4 2025 1.3m, Q1 2026 1.2m, Q2 2026 967.9k
-250.9k
-250,918
-20.6%
16
IRHYTHM TECHNOLOGIES INC
COM
IRTC
IRTC
269,650
$32.1m1.57%
1.57%
Added Shares held: Q3 2025 235.0k, Q4 2025 235.0k, Q1 2026 261.8k, Q2 2026 269.6k
+7.9k
+7,900
3.0%
17
INTUITIVE SURGICAL INC
COM NEW
ISRG
ISRG
76,460
$30.4m1.48%
1.48%
Reduced Shares held: Q3 2025 82.0k, Q4 2025 82.0k, Q1 2026 82.0k, Q2 2026 76.5k
-5.5k
-5,540
-6.8%
18
AGILON HEALTH INC
COM NEW
AGL
AGL
262,600
$28.1m1.37%
1.37%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 260.0k, Q2 2026 262.6k
+2.6k
+2,600
1.0%
19
UNITEDHEALTH GROUP INC
COM
UNH
UNH
63,750
$26.5m1.29%
1.29%
Added Shares held: Q3 2025 0, Q4 2025 40.8k, Q1 2026 53.0k, Q2 2026 63.8k
+10.8k
+10,750
20.3%
20
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
699,146
$26.0m1.27%
1.27%
Added Shares held: Q3 2025 721.5k, Q4 2025 692.5k, Q1 2026 650.3k, Q2 2026 699.1k
+48.9k
+48,876
7.5%
21
ERASCA INC
COM
ERAS
ERAS
1,402,150
$25.7m1.25%
1.25%
Added Shares held: Q3 2025 0, Q4 2025 951.7k, Q1 2026 1.1m, Q2 2026 1.4m
+298.7k
+298,681
27.1%
22
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
144,750
$24.4m1.19%
1.19%
Reduced Shares held: Q3 2025 89.8k, Q4 2025 125.5k, Q1 2026 150.4k, Q2 2026 144.8k
-5.7k
-5,700
-3.8%
23
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
464,625
$23.6m1.15%
1.15%
Reduced Shares held: Q3 2025 686.1k, Q4 2025 798.4k, Q1 2026 826.5k, Q2 2026 464.6k
-361.9k
-361,875
-43.8%
24
TENET HEALTHCARE CORP
COM NEW
THC
THC
125,000
$23.4m1.14%
1.14%
Unchanged Shares held: Q3 2025 125.0k, Q4 2025 125.0k, Q1 2026 125.0k, Q2 2026 125.0k
25
DEXCOM INC
COM
DXCM
DXCM
343,000
$23.1m1.13%
1.13%
Reduced Shares held: Q3 2025 316.9k, Q4 2025 347.3k, Q1 2026 355.6k, Q2 2026 343.0k
-12.6k
-12,600
-3.5%
26
ACLARIS THERAPEUTICS INC
COM
ACRS
ACRS
4,330,532
$22.9m1.12%
1.12%
Reduced Shares held: Q3 2025 4.6m, Q4 2025 4.5m, Q1 2026 4.5m, Q2 2026 4.3m
-142.1k
-142,118
-3.2%
27
MINIMED GROUP INC
COM
MMED
MMED
1,520,000
$22.7m1.11%
1.11%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.5m
+465.0k
+465,000
44.1%
28
BOSTON SCIENTIFIC CORP
COM
BSX
BSX
528,500
$22.6m1.10%
1.10%
Added Shares held: Q3 2025 360.2k, Q4 2025 399.1k, Q1 2026 515.3k, Q2 2026 528.5k
+13.2k
+13,200
2.6%
29
PHARVARIS N V
COM
PHVS
PHVS
648,333
$22.4m1.09%
1.09%
Added Shares held: Q3 2025 623.4k, Q4 2025 623.4k, Q1 2026 645.5k, Q2 2026 648.3k
+2.8k
+2,800
0.4%
30
AVALYN PHARMACEUTICALS INC
COM SHS
AVLN
AVLN
662,918
$21.8m1.07%
1.07%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 662.9k
31
HEMAB THERAPEUTICS HLDGS INC
COM SHS
COAG
COAG
575,432
$21.1m1.03%
1.03%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 575.4k
32
DYNE THERAPEUTICS INC
COM
DYN
DYN
942,154
$20.9m1.02%
1.02%
Reduced Shares held: Q3 2025 824.1k, Q4 2025 913.0k, Q1 2026 972.2k, Q2 2026 942.2k
-30.0k
-30,044
-3.1%
33
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
66,750
$20.1m0.98%
0.98%
Reduced Shares held: Q3 2025 74.2k, Q4 2025 71.2k, Q1 2026 74.0k, Q2 2026 66.8k
-7.2k
-7,250
-9.8%
34
COGENT BIOSCIENCES INC
COM
COGT
COGT
515,917
$20.0m0.97%
0.97%
Reduced Shares held: Q3 2025 1.0m, Q4 2025 849.0k, Q1 2026 624.2k, Q2 2026 515.9k
-108.2k
-108,238
-17.3%
35
AGIOS PHARMACEUTICALS INC
COM
AGIO
AGIO
532,563
$19.8m0.96%
0.96%
Reduced Shares held: Q3 2025 958.5k, Q4 2025 799.2k, Q1 2026 799.2k, Q2 2026 532.6k
-266.6k
-266,600
-33.4%
36
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
582,744
$19.7m0.96%
0.96%
Reduced Shares held: Q3 2025 595.9k, Q4 2025 557.2k, Q1 2026 588.8k, Q2 2026 582.7k
-6.0k
-6,050
-1.0%
37
VERA THERAPEUTICS INC
CL A
VERA
VERA
427,584
$18.3m0.90%
0.90%
Reduced Shares held: Q3 2025 617.4k, Q4 2025 568.6k, Q1 2026 503.6k, Q2 2026 427.6k
-76.0k
-76,001
-15.1%
38
TARSUS PHARMACEUTICALS INC
COM
TARS
TARS
277,087
$17.4m0.85%
0.85%
Added Shares held: Q3 2025 288.3k, Q4 2025 260.3k, Q1 2026 225.2k, Q2 2026 277.1k
+51.9k
+51,908
23.1%
39
HEARTFLOW INC
COM
HTFL
HTFL
573,500
$16.8m0.82%
0.82%
Added Shares held: Q3 2025 250.0k, Q4 2025 277.7k, Q1 2026 572.5k, Q2 2026 573.5k
+1.0k
+1,000
0.2%
40
MBX BIOSCIENCES INC
COM
MBX
MBX
298,218
$16.5m0.80%
0.80%
Added Shares held: Q3 2025 282.6k, Q4 2025 282.6k, Q1 2026 288.0k, Q2 2026 298.2k
+10.3k
+10,251
3.6%
41
CYTOKINETICS INC
COM NEW
CYTK
CYTK
187,980
$16.0m0.78%
0.78%
Added Shares held: Q3 2025 0, Q4 2025 35.9k, Q1 2026 45.4k, Q2 2026 188.0k
+142.6k
+142,616
314.4%
42
BICARA THERAPEUTICS INC
COM
BCAX
BCAX
535,286
$15.9m0.78%
0.78%
Added Shares held: Q3 2025 370.7k, Q4 2025 429.1k, Q1 2026 489.1k, Q2 2026 535.3k
+46.2k
+46,191
9.4%
43
PARABILIS MEDICINES INC
COM
PBLS
PBLS
578,028
$15.8m0.77%
0.77%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 578.0k
44
ZAI LAB LTD
ADR
ZLAB
ZLAB
814,707
$15.5m0.76%
0.76%
Unchanged Shares held: Q3 2025 791.2k, Q4 2025 811.5k, Q1 2026 814.7k, Q2 2026 814.7k
45
DANAHER CORPORATION
COM
DHR
DHR
76,300
$14.5m0.71%
0.71%
Added Shares held: Q3 2025 61.5k, Q4 2025 61.5k, Q1 2026 61.5k, Q2 2026 76.3k
+14.8k
+14,800
24.1%
46
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
456,551
$14.3m0.70%
0.70%
Added Shares held: Q3 2025 0, Q4 2025 386.9k, Q1 2026 386.9k, Q2 2026 456.6k
+69.6k
+69,636
18.0%
47
EVOLENT HEALTH INC
CL A
EVH
EVH
2,500,000
$13.6m0.66%
0.66%
Reduced Shares held: Q3 2025 3.0m, Q4 2025 2.7m, Q1 2026 2.7m, Q2 2026 2.5m
-175.0k
-175,000
-6.5%
48
PTC THERAPEUTICS INC
COM
PTCT
PTCT
162,298
$13.2m0.65%
0.65%
Added Shares held: Q3 2025 0, Q4 2025 61.9k, Q1 2026 161.8k, Q2 2026 162.3k
+500
+500
0.3%
49
MINERALYS THERAPEUTICS INC
COM
MLYS
MLYS
484,951
$13.1m0.64%
0.64%
Added Shares held: Q3 2025 408.3k, Q4 2025 427.6k, Q1 2026 439.8k, Q2 2026 485.0k
+45.2k
+45,200
10.3%
50
ZENAS BIOPHARMA INC
COM
ZBIO
ZBIO
502,077
$12.7m0.62%
0.62%
Unchanged Shares held: Q3 2025 580.7k, Q4 2025 502.1k, Q1 2026 502.1k, Q2 2026 502.1k
51
ARDELYX INC
COM
ARDX
ARDX
2,241,769
$11.4m0.56%
0.56%
Reduced Shares held: Q3 2025 2.3m, Q4 2025 2.3m, Q1 2026 2.3m, Q2 2026 2.2m
-57.7k
-57,704
-2.5%
52
INSPIRE MED SYS INC
COM
INSP
INSP
244,000
$10.9m0.53%
0.53%
Added Shares held: Q3 2025 110.5k, Q4 2025 131.0k, Q1 2026 131.8k, Q2 2026 244.0k
+112.2k
+112,200
85.1%
53
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
144,750
$10.8m0.53%
0.53%
Added Shares held: Q3 2025 85.0k, Q4 2025 103.5k, Q1 2026 128.2k, Q2 2026 144.8k
+16.5k
+16,500
12.9%
54
ALKERMES PLC
SHS
ALKS
ALKS
199,811
$10.5m0.51%
0.51%
Added Shares held: Q3 2025 106.5k, Q4 2025 139.2k, Q1 2026 184.0k, Q2 2026 199.8k
+15.8k
+15,825
8.6%
55
SUMMIT THERAPEUTICS INC
COM
SMMT
SMMT
715,000
$10.4m0.51%
0.51%
Added Shares held: Q3 2025 710.0k, Q4 2025 710.0k, Q1 2026 710.0k, Q2 2026 715.0k
+5.0k
+5,000
0.7%
56
AZENTA INC
COM
AZTA
AZTA
403,000
$10.3m0.50%
0.50%
Reduced Shares held: Q3 2025 540.4k, Q4 2025 569.1k, Q1 2026 569.1k, Q2 2026 403.0k
-166.1k
-166,100
-29.2%
57
INDIVIOR PHARMACEUTICALS INC
COM
INDV
INDV
245,500
$10.1m0.49%
0.49%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 245.5k
+45.5k
+45,500
22.8%
58
STRYKER CORPORATION
COM
SYK
SYK
29,000
$9.1m0.45%
0.45%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 14.8k, Q2 2026 29.0k
+14.2k
+14,200
96.0%
59
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
499,764
$9.0m0.44%
0.44%
Unchanged Shares held: Q3 2025 499.8k, Q4 2025 499.8k, Q1 2026 499.8k, Q2 2026 499.8k
60
CARIS LIFE SCIENCES INC
COM
CAI
CAI
487,500
$8.7m0.42%
0.42%
Reduced Shares held: Q3 2025 793.7k, Q4 2025 687.5k, Q1 2026 563.0k, Q2 2026 487.5k
-75.5k
-75,500
-13.4%
61
OMADA HEALTH INC
COM
OMDA
OMDA
373,000
$8.2m0.40%
0.40%
Reduced Shares held: Q3 2025 920.0k, Q4 2025 740.0k, Q1 2026 541.0k, Q2 2026 373.0k
-168.0k
-168,000
-31.1%
62
COMPASS THERAPEUTICS INC
COM
CMPX
CMPX
3,524,929
$7.7m0.38%
0.38%
Added Shares held: Q3 2025 4.5m, Q4 2025 3.9m, Q1 2026 3.3m, Q2 2026 3.5m
+219.6k
+219,621
6.6%
63
IMMUNOME INC
COM
IMNM
IMNM
347,666
$7.4m0.36%
0.36%
Unchanged Shares held: Q3 2025 0, Q4 2025 347.7k, Q1 2026 347.7k, Q2 2026 347.7k
64
EDAP TMS S A
SPONSORED ADR
FOCL
FOCL
1,386,000
$7.2m0.35%
0.35%
Added Shares held: Q3 2025 1.3m, Q4 2025 1.3m, Q1 2026 1.4m, Q2 2026 1.4m
+8.0k
+8,000
0.6%
65
PHREESIA INC
COM
PHR
PHR
696,900
$7.2m0.35%
0.35%
Added Shares held: Q3 2025 749.1k, Q4 2025 876.6k, Q1 2026 600.4k, Q2 2026 696.9k
+96.5k
+96,500
16.1%
66
OMEROS CORP
COM
OMER
OMER
718,499
$6.8m0.33%
0.33%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 718.5k
67
DEFINIUM THERAPEUTICS INC
COM SHS
DFTX
DFTX
143,187
$6.7m0.33%
0.33%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 143.2k
68
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
72,000
$6.3m0.31%
0.31%
Added Shares held: Q3 2025 0, Q4 2025 50.2k, Q1 2026 50.2k, Q2 2026 72.0k
+21.8k
+21,750
43.3%
69
JANUX THERAPEUTICS INC
COM
JANX
JANX
367,009
$5.6m0.28%
0.28%
Unchanged Shares held: Q3 2025 210.4k, Q4 2025 358.8k, Q1 2026 367.0k, Q2 2026 367.0k
70
MOBIA MED INC
COMMON STOCK
MOBI
MOBI
418,200
$5.6m0.27%
0.27%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 418.2k
71
ARCUS BIOSCIENCES INC
COM
RCUS
RCUS
180,000
$5.5m0.27%
0.27%
Unchanged Shares held: Q3 2025 0, Q4 2025 180.0k, Q1 2026 180.0k, Q2 2026 180.0k
72
THERMO FISHER SCIENTIFIC INC
COM
TMO
TMO
10,000
$5.0m0.24%
0.24%
Unchanged Shares held: Q3 2025 10.0k, Q4 2025 10.0k, Q1 2026 10.0k, Q2 2026 10.0k
73
TREVI THERAPEUTICS INC
COM
TRVI
TRVI
260,000
$4.8m0.24%
0.24%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 260.0k
74
SIONNA THERAPEUTICS INC
COM
SION
SION
99,429
$4.4m0.21%
0.21%
Unchanged Shares held: Q3 2025 99.4k, Q4 2025 99.4k, Q1 2026 99.4k, Q2 2026 99.4k
75
CVS HEALTH CORP
COM
CVS
CVS
40,000
$4.1m0.20%
0.20%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 40.0k, Q2 2026 40.0k
76
EYEPOINT PHARMACEUTICALS INC
COM NEW
EYPT
EYPT
268,519
$3.8m0.19%
0.19%
Added Shares held: Q3 2025 31.7k, Q4 2025 258.7k, Q1 2026 258.7k, Q2 2026 268.5k
+9.8k
+9,780
3.8%
77
OCULAR THERAPEUTIX INC
COM
OCUL
OCUL
383,716
$3.8m0.18%
0.18%
Unchanged Shares held: Q3 2025 300.0k, Q4 2025 345.8k, Q1 2026 383.7k, Q2 2026 383.7k
78
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
42,254
$3.8m0.18%
0.18%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 42.3k
79
TALPHERA INC
COM NEW
TLPH
TLPH
3,589,186
$3.7m0.18%
0.18%
Unchanged Shares held: Q3 2025 3.6m, Q4 2025 3.6m, Q1 2026 3.6m, Q2 2026 3.6m
80
ROIVANT SCIENCES LTD
SHS
ROIV
ROIV
101,000
$3.6m0.17%
0.17%
Added Shares held: Q3 2025 0, Q4 2025 88.8k, Q1 2026 97.0k, Q2 2026 101.0k
+4.0k
+4,000
4.1%
81
VAXCYTE INC
COM
PCVX
PCVX
60,250
$3.5m0.17%
0.17%
Unchanged Shares held: Q3 2025 11.1k, Q4 2025 47.0k, Q1 2026 60.2k, Q2 2026 60.2k
82
NEUROGENE INC
COM
NGNE
NGNE
106,750
$3.4m0.16%
0.16%
Added Shares held: Q3 2025 104.3k, Q4 2025 104.3k, Q1 2026 104.3k, Q2 2026 106.8k
+2.4k
+2,411
2.3%
83
CENTURY THERAPEUTICS INC
COM
IPSC
IPSC
1,304,347
$3.2m0.16%
0.16%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.3m, Q2 2026 1.3m
84
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
360,000
$3.1m0.15%
0.15%
Added Shares held: Q3 2025 302.5k, Q4 2025 302.5k, Q1 2026 350.0k, Q2 2026 360.0k
+10.0k
+10,000
2.9%
85
NOVO-NORDISK A S
ADR
NVO
NVO
63,500
$3.0m0.15%
0.15%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 90.0k, Q2 2026 63.5k
-26.5k
-26,500
-29.4%
86
OLEMA PHARMACEUTICALS INC
COM
OLMA
OLMA
235,178
$2.9m0.14%
0.14%
Added Shares held: Q3 2025 0, Q4 2025 98.2k, Q1 2026 170.4k, Q2 2026 235.2k
+64.8k
+64,800
38.0%
87
NERVGEN PHARMA CORP
COM
NGEN
NGEN
1,208,231
$2.5m0.12%
0.12%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
88
MEDTRONIC PLC
SHS
MDT
MDT
30,900
$2.4m0.12%
0.12%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 30.9k
89
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS
SPONSORED ADS
59,000
$2.0m0.10%
0.10%
Added Shares held: Q3 2025 0, Q4 2025 45.5k, Q1 2026 45.5k, Q2 2026 59.0k
+13.5k
+13,500
29.7%
90
DIANTHUS THERAPEUTICS INC
COM
DNTH
DNTH
20,326
$2.0m0.10%
0.10%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 26.8k, Q2 2026 20.3k
-6.4k
-6,431
-24.0%
91
SAGIMET BIOSCIENCES INC
COM SER A
SGMT
SGMT
250,000
$1.9m0.09%
0.09%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
92
CAPRICOR THERAPEUTICS INC
COM NEW
CAPR
CAPR
74,448
$1.8m0.09%
0.09%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 74.4k
93
LENZ THERAPEUTICS INC
COM
LENZ
LENZ
257,460
$1.5m0.07%
0.07%
Unchanged Shares held: Q3 2025 236.2k, Q4 2025 257.5k, Q1 2026 257.5k, Q2 2026 257.5k
94
ALTIMMUNE INC
COM NEW
ALT
ALT
471,465
$1.4m0.07%
0.07%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 471.5k
95
KAILERA THERAPEUTICS INC
COMMON STOCK
KLRA
KLRA
65,000
$1.4m0.07%
0.07%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 65.0k
96
SURGERY PARTNERS INC
COM
SGRY
SGRY
84,000
$1.4m0.07%
0.07%
Reduced Shares held: Q3 2025 0, Q4 2025 310.0k, Q1 2026 208.0k, Q2 2026 84.0k
-124.0k
-124,000
-59.6%
97
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
5,500
$1.3m0.07%
0.07%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.5k
98
ORUKA THERAPEUTICS INC
COM
ORKA
ORKA
12,051
$1.1m0.06%
0.06%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.1k, Q2 2026 12.1k
+7.9k
+7,928
192.3%
99
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
25,500
$994.8k0.05%
0.05%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 96.0k, Q2 2026 25.5k
-70.5k
-70,500
-73.4%
100
LEGEND BIOTECH CORP
SPONSORED ADS
LEGN
LEGN
33,500
$967.5k0.05%
0.05%
Reduced Shares held: Q3 2025 0, Q4 2025 33.8k, Q1 2026 40.5k, Q2 2026 33.5k
-7.0k
-7,000
-17.3%